title: Candesartan cilexetil and enalapril are of equivalent efficacy in patients with mild to moderate hypertension.
authors.affiliation: Centro di Fisiologia Clinica e Ipertensione, University of Milan, IRCCS Ospedale Maggiore, Italy.
authors.forename: A
authors.initials: A
authors.lastname: Zanchetti
authors.forename: S
authors.initials: S
authors.lastname: Omboni
authors.forename: C
authors.initials: C
authors.lastname: Di Biagio
mesh_terms: D000293:Adolescent; D000328:Adult; D000368:Aged; D057911:Angiotensin Receptor Antagonists; D000806:Angiotensin-Converting Enzyme Inhibitors / Q000627:therapeutic use*; D000959:Antihypertensive Agents / Q000627:therapeutic use*; D001562:Benzimidazoles / Q000009:adverse effects / Q000627:therapeutic use*; D001713:Biphenyl Compounds / Q000009:adverse effects / Q000627:therapeutic use*; D004656:Enalapril / Q000009:adverse effects / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D006973:Hypertension / Q000188:drug therapy*; D008297:Male; D008875:Middle Aged; D013777:Tetrazoles
chemical_list: D057911:Angiotensin Receptor Antagonists; D000806:Angiotensin-Converting Enzyme Inhibitors; D000959:Antihypertensive Agents; D001562:Benzimidazoles; D001713:Biphenyl Compounds; D013777:Tetrazoles; D004656:Enalapril; C077793:candesartan cilexetil